Amgen (AMGN) Tops Q3 EPS by 57c, Reves Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $402.98 -0.01%
EPS Growth %: +2.7%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
EPS Growth %: +2.7%
Financial Fact:
Other revenues: 295M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q3 EPS of $4.37, $0.57 better than the analyst estimate of $3.80. Revenue for the quarter came in at $6.4 billion versus the consensus estimate of $6.35 billion.
GUIDANCE:
Amgen sees FY2020 EPS of $15.80-$16.15, versus the consensus of $15.77. Amgen sees FY2020 revenue of $25.1-25.5 billion, versus the consensus of $25.41 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald
- McCormick & Co. (MKC) Tops Q3 EPS by 10c, Beats on Revenue; Offers EPS Guidance
- Goldman Sachs sees AI investment adding to European growth in 2026
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
